Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism
1 Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania; and 2 Department of Metabolic Diseases, Bristol-Myers Squibb Company, Princeton, New Jersey Submitted 26 November 2008 ; accepted in final form 22 December 2008 ABSTRACT Monoa...
Gespeichert in:
Veröffentlicht in: | American journal of physiology: endocrinology and metabolism 2009-07, Vol.297 (1), p.E10-E18 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 1 Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania; and 2 Department of Metabolic Diseases, Bristol-Myers Squibb Company, Princeton, New Jersey
Submitted 26 November 2008
; accepted in final form 22 December 2008
ABSTRACT
Monoacyglycerol acyltransferases (MGATs) and diacylglycerol acyltransferases (DGATs) catalyze two consecutive steps of enzyme reactions in the synthesis of triacylglycerols (TAGs). The metabolic complexity of TAG synthesis is reflected by the presence of multiple isoforms of MGAT and DGAT enzymes that differ in catalytic properties, subcellular localization, tissue distribution, and physiological functions. MGAT and DGAT enzymes play fundamental roles in the metabolism of monoacylglycerol (MAG), diacylglycerol (DAG), and triacylglycerol (TAG) that are involved in many aspects of physiological functions, such as intestinal fat absorption, lipoprotein assembly, adipose tissue formation, signal transduction, satiety, and lactation. The recent progress in the phenotypic characterization of mice deficient in MGAT and DGAT enzymes and the development of chemical inhibitors have revealed important roles of these enzymes in the regulation of energy homeostasis and insulin sensitivity. Consequently, selective inhibition of MGAT or DGAT enzymes by synthetic compounds may provide novel treatment for obesity and its related metabolic complications.
monoacylglycerol acyltransferase; diacylglycerol acyltransferase; obesity
Address for reprint requests and other correspondence: Y. Shi, Dept. of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, 500 University Dr., Hershey, PA (e-mail: YSHI{at}hmc.psu.edu ) |
---|---|
ISSN: | 0193-1849 1522-1555 |
DOI: | 10.1152/ajpendo.90949.2008 |